TLR2 and infection: Another point that might be considered as a prospective target for anti-arenaviral therapy is the Toll-like receptor 2 (TLR2) pathway that activates host defense mechanisms in order to prevent and eradicate infections and participates in the generation of the adaptive immune response [121].